Cédric Poyet

50 posts

Cédric Poyet banner
Cédric Poyet

Cédric Poyet

@CPMS1B

Urologist, MD, University Hospital of Zürich

Zurich, Switzerland انضم Ocak 2015
131 يتبع57 المتابعون
Markus Eckstein
Markus Eckstein@Markuseckstein3·
Should we reconsider Gleason 3 as non cancer growth pattern ? Interesting survey results @EurUrolFocus ! what do you think about that? @Uroweb @niklas_kluemper @Uromigos @urotoday @imedverse @OncoAlert @ASCO Personally I am ambivalent: ➡️ Gleason 3 is an invasive carcinoma by definition and grows invasively. ➡️ but often not clinically significant, and overtreatment of Grade Group 1 patients is real. ➡️ But misdiagnosis of higher Gleason patterns as pattern 3 or undersampling of higher Gleason scores is also real🥵‼️ We had the chance to learn a lot from PREFERE trial (pubmed.ncbi.nlm.nih.gov/32886212/) but it was killed …
Eur Urol Focus@EurUrolFocus

Physician Perception of Grade Group 1 Prostate Cancer buff.ly/3QSCN44 @Saouduro @laen120er @GladellPaner @aleberlin2 @dr_coops @uroegg #UroSoMe #Medtwitter #ProstateCancer

English
2
5
11
5.5K
Markus Eckstein
Markus Eckstein@Markuseckstein3·
I am with you Michelle !! There are actually a lot of cancer types that never or rarely spread to other organs but are considered to be malignant … papillary urothelial carcinoma and basal cell carcinomas for example.. If we stop considering Gleason 3 as cancer than you would never know who should undergo active surveillance … it can progress .. So if we follow that line of argumentation we would have to stop calling low grade papillary UC cancer, too…
English
2
1
2
330
Cédric Poyet أُعيد تغريده
Ruben De Groote
Ruben De Groote@Ruben_De_Groote·
Was a great honour and privilege to be invited by @deberli and @CPMS1B for giving a lecture on “Optimizing outcomes in robotics”. Technology and Proficiency Based Progression training go hand in hand 🤖 @RealProstateDoc @MRoupret @AalstOlv @OLVZaalst @orsiacademy
Ruben De Groote tweet mediaRuben De Groote tweet mediaRuben De Groote tweet media
Daniel Eberli@deberli

Herzlichen Dank an alle Beteiligten des 13. Interdisziplinären Uro-Onkologischen Symposiums 2023! Exzellente Redner und spannende Diskussionen! Save the Date: 02.02.2024 usz.ch/en/interdiscip…

Aalst, België 🇧🇪 English
0
2
9
1.8K
Cédric Poyet أُعيد تغريده
Daniel Eberli
Daniel Eberli@deberli·
Herzlichen Dank an alle Beteiligten des 13. Interdisziplinären Uro-Onkologischen Symposiums 2023! Exzellente Redner und spannende Diskussionen! Save the Date: 02.02.2024 usz.ch/en/interdiscip…
Daniel Eberli tweet media
Deutsch
0
2
4
2.3K
Cédric Poyet أُعيد تغريده
Clive Peedell
Clive Peedell@cpeedell·
Dear @JAMAOnc, I politely suggest that you commit to an investigation into how & why the #ENACT trial was published. There is potential for enormous harm to men with early & intermediate prostate cancer. An urgent editorial with retraction of the article should be a minimum #pcsm
English
2
14
76
0
Cédric Poyet أُعيد تغريده
Toni Choueiri, MD
Toni Choueiri, MD@DrChoueiri·
It is this time of the year again: TOP 20 GU Oncology clinical trials published in 2021: Some negative, some positive, some led to @FDAOncology approval; we learned from all! Feel free to add & retweet & tag anyone involved This is not an exhaustive list @OncoAlert
Toni Choueiri, MD tweet media
English
16
221
484
0
Cédric Poyet
Cédric Poyet@CPMS1B·
@retolipp @johnlswiss @tagesanzeiger das ist nur eine seite der medaille. wenn es keine vergütung der privat pat gäbe (quersubventionierung) wäre es schon lange so wie US, UK Aus:allgemeinvers. würden nicht mehr dieselbe behandlungsqualität erhalten (bs teurere kardio stents, davinci chirurgie, etc) da kein geld da
Deutsch
0
0
0
0
Reto Lipp
Reto Lipp@retolipp·
@johnlswiss @tagesanzeiger Gerade bei Privatpatienten werden vielfach unnötige Operationen gemacht. Diese müssen dann Defizite in den Spitälern decken.
Deutsch
5
1
8
0
Cédric Poyet أُعيد تغريده
Andrew Vickers
Andrew Vickers@VickersBiostats·
A discussion I’m having right now: can a university in Sweden transfer completely de-identified cancer data to a US academic institution and keep a key in case of data questions? No, because of a theoretical privacy risk. Insane privacy regulations are killing cancer research.
English
8
8
65
0
Cédric Poyet أُعيد تغريده
Brian Tyler Cohen
Brian Tyler Cohen@briantylercohen·
So Dr. Desai won’t be invited back onto Fox News but God damn it was worth it.
English
940
8.5K
32.6K
0
Cédric Poyet أُعيد تغريده
Jocelyn J. Fitzgerald MD
Jocelyn J. Fitzgerald MD@jjfitzgeraldMD·
How can any healthcare system try to say that you can’t have a mask to examine an asymptomatic patient (a total stranger, very possible carrier) but out in the real world we aren’t allowed to be within 6 feet of each other because it’s too risky? That’s illogical. #WeNeedPPE
English
35
416
1.4K
0
Cédric Poyet
Cédric Poyet@CPMS1B·
@BadarMian1 people still dont see the threat of #COVID19. But why is a 84y old male anyway checked for localized prostate cancer?!
English
0
0
1
0